TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinical course of patients with Interstitial Lung Diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Emergency and Hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma concentrations of JNJ-38518168
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of ketoconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staff satisfaction with hand hygiene formula
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proper hand hygiene compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Device-Related Revisions
Endpoint domain: Adverse events/effects
Primary endpoint: Metal Ion Concentration in Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Mean Systolic Wall Stress/Rate-corrected Velocity of Fiber Shortening Relation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary Function (FEV1 and FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of Hypercoagulability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Follicular development rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of iso-group and/or compatible units administered for octaplasLG®
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pharmacokinetics of NKTR-102 and its metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertional torque measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge, Attitude and Practice Levels of Healthcare Professionals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fugl-Meyer (Motor control)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Hand Evaluation (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Jebsen Taylor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of circulating lipid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in thigh muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Transcutaneous oxygen tension (PtcO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Unbalanced TKRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incremental area under the curve for capillary blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of patients who could forego a surveillance biopsy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average velocity of the cerebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in ADAS-Cog11 Score at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Seroma Formation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfactory Clinical Response at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of Inpatient Care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Health Care Provider Visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of ER Visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patency Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean Diameter of the Study Graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Clinically meaningful changes in physical examination findings, vital signs or blood chemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in WOMAC Function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage Change in Physical Activity Scale for the Elderly
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage Change in 30-s chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage Change in 20 meter fast-paced walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage Change in Stair-climb test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Subjects With Microbiological Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Corrected QT Interval During Nocturnal Hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Corrected QT Interval During Day Time Hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline Symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of Adverse Events, Grade 3 or Higher
Endpoint domain: Adverse events/effects
Primary endpoint: Total Muscle Volume (TMV) of the Treated Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percent Change of Total Muscle Volume (TMV) of the Treated Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematic movement analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tcpO2 changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tcpCO2 changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of pulse types and varieties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Induction of hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Participation in opportunities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Functions of patients post-hemipelvectomy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Falls Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Response to melatonin as a sleep-wake rhythm synchronizer
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Device conformability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Pediatric Asthma Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in vaginal maturation index (VMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Anthropometric changes (Body weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anthropometric changes (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in strength performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bayley Scales of Infant and Toddler Development-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stoma QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-management behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Family Interaction Task (FIT)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Brief Symptom Inventory 18 (BSI-18) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of (serious) adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: changes of important laboratory parameters (liver and renal function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: All-Cause Mortality at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Oxygenation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety and tolerability of GL-ONC1
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom From Device/Procedure Related Major Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: AUC (0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Posttraumatic Stress Disorder Checklist score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of wanting for protein-rich foods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Size of induration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test ability to identify positive results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: client retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Measure of distress in patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Measure of distress in caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: New-onset type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New-onset CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of unprotected sex episodes
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in reported HIV medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the frequency of condom use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Adult Body Mass Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Duration of Daily Moderate to Vigorous Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Score for Target Child Over 12months on the Family Nutrition and Physical Activity Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: minimum concentration of study drug in cerebrospinal fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD signal change in ROIs during alcohol cue-reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD signal change in ROIs during INHIBIT cue-reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD signal change in ROIs during INDULGE cue-reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of En-masse retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pupillary reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in accommodation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI Activation Analysis/Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Time Attending to Social Stimuli
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Safety and comparative bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic adequacy of NVP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid function in the development of STAAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Thyroid function in the prognosis of STAAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AzBio sentence score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of dose limiting toxicity of ribociclib
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with a >= 50% reduction in prostate specific antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in myocardial iron content assessed by CMR T2*
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in myocardial iron content assessed by CMR T1-mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of steatosis detected by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of abdominal adhesion intra operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Propofol Effect-site Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of fibrosis within the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number, frequency and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Recordings of Significant Drift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of disease free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of carcinoma in situ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pulmonary hypertension improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Motor function test (lower limb muscle strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 25 Foot Walk (T25FW) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity for lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Infectious Myocarditis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Myocardial Rupture
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Neoplasm
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Immune Sensitization
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR) Per Blinded Independent Central Review (BICR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective Response Rate (ORR) Per Investigator's Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Significant clinical improvement in ASIA impairment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant clinical improvement in general condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator-assessed (RECIST) v1.1 Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: biochemical markers of brain ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intraoperative cerebral oxymetry data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety in terms of adverse and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With 2 Negative Fungal Cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tactile acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OSA risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraceptive Implant Continuation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Weight Gain at 26 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Point Prevalence Smoking Abstinence at 26 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of Preconception Health Risks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Neutrophil Count Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PAI/ultrasound signatures from ovaries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell viability ratio of synovial membrane MSC and infrapatellar fat pad MSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doubling time of synovial membrane MSC and infrapatellar fat pad MSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage expression of cluster differentiation surface markers of synovial membrane MSC and infrapatellar fat pad MSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPR rate in stage III population evaluated by BIPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EFS in stage III population evaluated by investigators
Endpoint domain: Mortality/survival
Primary endpoint: MPR rate in stage II-III population evaluated by BIPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EFS in stage II-III population evaluated by investigators
Endpoint domain: Mortality/survival
Primary endpoint: Change in walking abilities, balance and mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hydrogen and methane breath levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients developing grade 1-4 radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Achieving PASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of Participants With PGA Score of Clear or Minimal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: WHO Disability Assessment Scale 2 Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: composite of major cardiac and cerebrovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute Change in Brachial Artery Flow-mediated Dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prefrontal neuronal functional integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the curve (AUC) of capecitabine and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of ventilator cycling (RRmec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of days without cannabis use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Umbilical Cord pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effects on markers of virus replication and expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of cardiac arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endothelial function (Flow Mediated Dilatation in %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Discontinued Treatment Due to Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Any Drug-related Grade 2 to 4 Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Grade 3 or 4 Treatment-emergent Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With Device-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Post Traumatic Stress Disorder (PTSD) Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Non-inferiority of treatment
Endpoint domain: Mortality/survival
Primary endpoint: Corneal allograft rejection or graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on concentration of biochemical parameters for hunger sensation and hormonal status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change on concentration of biochemical parameters for glico-metabolic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change on state of hunger, fullness, desire to eat, satiety and prospective food consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status